Search Results

Business

Temple Street Biotech Initiates Groundbreaking Therapeutic Antibody for Alzheimer’s Disease

Temple Street Biotech is proud to announce the initiation of a pioneering therapeutic antibody targeting prion protein for the treatment of Alzheimer’s disease.

May 21, 2024

·

2 min read

Policy

JUVÉDERM® VOLUMA® XC For Temple Hollows Receives U.S. FDA Approval

Allergan Aesthetics, an AbbVie company, announced the U.S. FDA approval of JUVÉDERM® VOLUMA® XC for injection in the temple region to improve moderate to severe temple hollowing in adults over the age of 21.

March 5, 2024

·

10 min read

Temple Health Joins U.S. Study of Artificial Intelligence Diagnostic System for DVT Detection

Temple Health is partnering with ThinkSono, a UK-based AI company, to study a new artificial intelligence -powered ultrasound technology that enables more rapid and portable diagnosis of deep vein thrombosis.

February 13, 2024

·

2 min read

Three Medical Journals Investigate Temple University for Potential Data Manipulation

Three medical journals have launched investigations into publications by researchers at Temple University to determine if there was data manipulation.

September 14, 2022

·

4 min read

·

Mark Terry

Genetown

Temple Therapeutics Reveals Breakthrough Findings on Ovarian Cancer at AACR 2023

Temple Therapeutics presented new in vitro and in vivo data on TTX335o, the first drug candidate from the company’s platform that won the Eurostar Eureka peer-reviewed grant process in 2019 for ovarian cancer.

May 8, 2023

·

6 min read

Pharm Country

Temple University Hospital Adopts Masimo Centroid™

Masimo and Temple Health announced that Temple University Hospital, a 722-bed academic medical center located in Philadelphia, is expanding its use of Masimo technologies with Centroid™, an advanced wireless patient position, orientation, activity, and respiration rate sensor, at 100 beds across its ICU units.

February 7, 2022

·

13 min read

ONO Enters into a University-Wide, Research Alliance Agreement with Harvard University

Ono Pharmaceutical Co., Ltd. announced that it entered into a five-year, university-wide strategic research alliance agreement with Harvard University aiming at validating novel therapeutic targets.

March 11, 2024

·

3 min read

Genetown

Ground-Breaking Human Trial by Temple Therapeutics Solves 187-Year-Old Surgical Mystery of Eradicating Painful Adhesions

Temple Therapeutics released the publication of its Phase 2 trial for the first pharmaceutical known as TTX333 which shows the complete prevention of post-surgical adhesions in 93.3% of patients undergoing gynecological surgery.

June 5, 2023

·

3 min read

Biotech Beach

Masimo and Temple Health Form Innovation Collaboration with Focus on Hospital Automation and Telehealth Initiatives

Masimo, a leading global provider of medical technology and automation solutions, and Temple Health, Philadelphia’s 979-bed academic health system, announced that they are entering into a strategic innovation collaboration.

March 7, 2023

·

11 min read

Pictured: Astellas' Americas headquarters in Illin

Layoffs

Astellas Cuts 24 Universal Cells Roles in Seattle, Transfers 12 to Japan

Astellas is opening a second location of Universal Cells, its wholly owned subsidiary, at a research campus in Japan and transferring 12 roles from Universal’s Seattle location.

October 10, 2024

·

1 min read

·

Angela Gabriel